| UniProt ID | PEX14_HUMAN | |
|---|---|---|
| UniProt AC | O75381 | |
| Protein Name | Peroxisomal membrane protein PEX14 | |
| Gene Name | PEX14 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 377 | |
| Subcellular Localization |
Peroxisome membrane Peripheral membrane protein Cytoplasmic side . |
|
| Protein Description | Peroxisome membrane protein that is an essential component of the peroxisomal import machinery. Functions as a docking factor for the predominantly cytoplasmic PTS1 receptor (PEX5). Plays a key role for peroxisome movement through a direct interaction with tubulin.. | |
| Protein Sequence | MASSEQAEQPSQPSSTPGSENVLPREPLIATAVKFLQNSRVRQSPLATRRAFLKKKGLTDEEIDMAFQQSGTAADEPSSLGPATQVVPVQPPHLISQPYSPAGSRWRDYGALAIIMAGIAFGFHQLYKKYLLPLILGGREDRKQLERMEAGLSELSGSVAQTVTQLQTTLASVQELLIQQQQKIQELAHELAAAKATTSTNWILESQNINELKSEINSLKGLLLNRRQFPPSPSAPKIPSWQIPVKSPSPSSPAAVNHHSSSDISPVSNESTSSSPGKEGHSPEGSTVTYHLLGPQEEGEGVVDVKGQVRMEVQGEEEKREDKEDEEDEEDDDVSHVDEEDCLGVQREDRRGGDGQINEQVEKLRRPEGASNESERD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MASSEQAEQ ------CCCHHHCCC | 23.05 | 25944712 | |
| 3 | Phosphorylation | -----MASSEQAEQP -----CCCHHHCCCC | 32.86 | 21955146 | |
| 4 | Phosphorylation | ----MASSEQAEQPS ----CCCHHHCCCCC | 24.96 | 21955146 | |
| 11 | Phosphorylation | SEQAEQPSQPSSTPG HHHCCCCCCCCCCCC | 55.18 | 21955146 | |
| 14 | Phosphorylation | AEQPSQPSSTPGSEN CCCCCCCCCCCCCCC | 38.93 | 21955146 | |
| 15 | Phosphorylation | EQPSQPSSTPGSENV CCCCCCCCCCCCCCC | 45.35 | 25159151 | |
| 15 | Ubiquitination | EQPSQPSSTPGSENV CCCCCCCCCCCCCCC | 45.35 | 22817900 | |
| 16 | Phosphorylation | QPSQPSSTPGSENVL CCCCCCCCCCCCCCC | 35.69 | 25159151 | |
| 19 | Phosphorylation | QPSSTPGSENVLPRE CCCCCCCCCCCCCCC | 27.48 | 21955146 | |
| 34 (in isoform 1) | Ubiquitination | - | 37.58 | 21890473 | |
| 34 (in isoform 2) | Ubiquitination | - | 37.58 | 21890473 | |
| 34 | Ubiquitination | PLIATAVKFLQNSRV HHHHHHHHHHHCCCC | 37.58 | 23000965 | |
| 34 | Acetylation | PLIATAVKFLQNSRV HHHHHHHHHHHCCCC | 37.58 | 19608861 | |
| 39 | Phosphorylation | AVKFLQNSRVRQSPL HHHHHHCCCCCCCHH | 21.13 | 27067055 | |
| 44 | Phosphorylation | QNSRVRQSPLATRRA HCCCCCCCHHHHHHH | 16.00 | 30266825 | |
| 48 | Ubiquitination | VRQSPLATRRAFLKK CCCCHHHHHHHHHHH | 28.50 | 21890473 | |
| 96 | Phosphorylation | VQPPHLISQPYSPAG CCCCCCCCCCCCCCC | 31.31 | 22468782 | |
| 104 | Phosphorylation | QPYSPAGSRWRDYGA CCCCCCCCCHHHHHH | 30.67 | 22468782 | |
| 149 | Ubiquitination | RKQLERMEAGLSELS HHHHHHHHHHHHHHH | 45.89 | 22817900 | |
| 156 | Ubiquitination | EAGLSELSGSVAQTV HHHHHHHHHHHHHHH | 25.60 | 21890473 | |
| 168 | O-linked_Glycosylation | QTVTQLQTTLASVQE HHHHHHHHHHHHHHH | 32.16 | OGP | |
| 170 (in isoform 2) | Ubiquitination | - | 3.67 | 21890473 | |
| 170 | Ubiquitination | VTQLQTTLASVQELL HHHHHHHHHHHHHHH | 3.67 | 22817900 | |
| 177 (in isoform 2) | Ubiquitination | - | 3.06 | 21890473 | |
| 177 | Ubiquitination | LASVQELLIQQQQKI HHHHHHHHHHHHHHH | 3.06 | 21890473 | |
| 184 | Ubiquitination | LIQQQQKIQELAHEL HHHHHHHHHHHHHHH | 3.15 | 22817900 | |
| 191 | Ubiquitination | IQELAHELAAAKATT HHHHHHHHHHHHCHH | 2.56 | 21890473 | |
| 194 | Ubiquitination | LAHELAAAKATTSTN HHHHHHHHHCHHCCH | 9.08 | 22817900 | |
| 195 | Ubiquitination | AHELAAAKATTSTNW HHHHHHHHCHHCCHH | 41.35 | 29967540 | |
| 201 | Ubiquitination | AKATTSTNWILESQN HHCHHCCHHHHHCCC | 24.45 | 21890473 | |
| 213 | Ubiquitination | SQNINELKSEINSLK CCCHHHHHHHHHHHH | 39.60 | 21906983 | |
| 213 (in isoform 1) | Ubiquitination | - | 39.60 | 21890473 | |
| 218 | Phosphorylation | ELKSEINSLKGLLLN HHHHHHHHHHHHHHC | 36.80 | 30576142 | |
| 220 | Ubiquitination | KSEINSLKGLLLNRR HHHHHHHHHHHHCCC | 47.54 | 22817900 | |
| 220 (in isoform 1) | Ubiquitination | - | 47.54 | 21890473 | |
| 227 | Ubiquitination | KGLLLNRRQFPPSPS HHHHHCCCCCCCCCC | 41.22 | 22817900 | |
| 232 | Phosphorylation | NRRQFPPSPSAPKIP CCCCCCCCCCCCCCC | 31.55 | 30266825 | |
| 234 | Phosphorylation | RQFPPSPSAPKIPSW CCCCCCCCCCCCCCC | 62.63 | 30266825 | |
| 234 | Ubiquitination | RQFPPSPSAPKIPSW CCCCCCCCCCCCCCC | 62.63 | 21890473 | |
| 240 | Phosphorylation | PSAPKIPSWQIPVKS CCCCCCCCCCCCCCC | 34.78 | 25002506 | |
| 246 | Ubiquitination | PSWQIPVKSPSPSSP CCCCCCCCCCCCCCC | 51.82 | 29967540 | |
| 247 | Phosphorylation | SWQIPVKSPSPSSPA CCCCCCCCCCCCCCC | 30.74 | 25159151 | |
| 249 | Phosphorylation | QIPVKSPSPSSPAAV CCCCCCCCCCCCCHH | 44.50 | 25159151 | |
| 251 | Phosphorylation | PVKSPSPSSPAAVNH CCCCCCCCCCCHHCC | 53.98 | 25159151 | |
| 252 | Phosphorylation | VKSPSPSSPAAVNHH CCCCCCCCCCHHCCC | 23.18 | 25159151 | |
| 260 | Phosphorylation | PAAVNHHSSSDISPV CCHHCCCCCCCCCCC | 24.80 | 25159151 | |
| 261 | Phosphorylation | AAVNHHSSSDISPVS CHHCCCCCCCCCCCC | 27.89 | 25159151 | |
| 262 | Phosphorylation | AVNHHSSSDISPVSN HHCCCCCCCCCCCCC | 41.81 | 25159151 | |
| 265 | Phosphorylation | HHSSSDISPVSNEST CCCCCCCCCCCCCCC | 25.00 | 25159151 | |
| 268 | Phosphorylation | SSDISPVSNESTSSS CCCCCCCCCCCCCCC | 37.96 | 28176443 | |
| 271 | Phosphorylation | ISPVSNESTSSSPGK CCCCCCCCCCCCCCC | 37.53 | 23401153 | |
| 272 | Phosphorylation | SPVSNESTSSSPGKE CCCCCCCCCCCCCCC | 26.84 | 25159151 | |
| 273 | Phosphorylation | PVSNESTSSSPGKEG CCCCCCCCCCCCCCC | 37.79 | 26503892 | |
| 274 | Phosphorylation | VSNESTSSSPGKEGH CCCCCCCCCCCCCCC | 40.41 | 25159151 | |
| 275 | Phosphorylation | SNESTSSSPGKEGHS CCCCCCCCCCCCCCC | 37.12 | 26503892 | |
| 282 | Phosphorylation | SPGKEGHSPEGSTVT CCCCCCCCCCCCEEE | 35.19 | 30266825 | |
| 286 | Phosphorylation | EGHSPEGSTVTYHLL CCCCCCCCEEEEEEC | 20.31 | 30266825 | |
| 287 | Phosphorylation | GHSPEGSTVTYHLLG CCCCCCCEEEEEECC | 27.94 | 29255136 | |
| 289 | Phosphorylation | SPEGSTVTYHLLGPQ CCCCCEEEEEECCCC | 12.81 | 29255136 | |
| 290 | Phosphorylation | PEGSTVTYHLLGPQE CCCCEEEEEECCCCC | 6.02 | 29255136 | |
| 299 | Ubiquitination | LLGPQEEGEGVVDVK ECCCCCCCCCEEECC | 35.88 | 21890473 | |
| 306 | Ubiquitination | GEGVVDVKGQVRMEV CCCEEECCCEEEEEE | 38.88 | 33845483 | |
| 320 | Ubiquitination | VQGEEEKREDKEDEE ECCCHHCCCCCCCCC | 61.70 | 21890473 | |
| 320 (in isoform 2) | Ubiquitination | - | 61.70 | 21890473 | |
| 334 | Ubiquitination | EDEEDDDVSHVDEED CCCCCCCCCCCCHHH | 5.69 | 21890473 | |
| 335 | Phosphorylation | DEEDDDVSHVDEEDC CCCCCCCCCCCHHHH | 25.45 | 21955146 | |
| 344 | Ubiquitination | VDEEDCLGVQREDRR CCHHHHCCCCCCCCC | 21.61 | 21890473 | |
| 351 | Methylation | GVQREDRRGGDGQIN CCCCCCCCCCCCHHH | 66.81 | 115487039 | |
| 363 | Ubiquitination | QINEQVEKLRRPEGA HHHHHHHHHHCCCCC | 48.73 | 22817900 | |
| 363 (in isoform 1) | Ubiquitination | - | 48.73 | 21890473 | |
| 371 | Phosphorylation | LRRPEGASNESERD- HHCCCCCCCCCCCC- | 52.57 | 21955146 | |
| 374 | Phosphorylation | PEGASNESERD---- CCCCCCCCCCC---- | 42.03 | 21955146 | |
| 377 | Ubiquitination | ASNESERD------- CCCCCCCC------- | 59.84 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PEX14_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PEX14_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PEX14_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00205 | Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NAL | |||||
| OMIM Disease | ||||||
| 614887 | Peroxisome biogenesis disorder complementation group K (PBD-CGK) | |||||
| 614887 | Peroxisome biogenesis disorder 13A (PBD13A) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-34, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335, AND MASSSPECTROMETRY. | |